Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Syncona Share News (SYNC)
SYNC Share
Price
SYNC Share
News
SYNC Share
Chat
SYNC Share
Trades64
SYNC
Live RNS
SYNC Share
Charts
SYNC Level 2
Console
SYNC Live
Share Price
SYNC Broker
Ratings
SYNC Directors
Deals
SYNC Financial
Diary
SYNC
Fundamentals
SYNC Short
Positions
SYNC
Media
SYNC Company
Research
SYNC Company
Timeline
Share Price Information for Syncona (SYNC)
Last checked at -
Last checked at 
Intraday Syncona Share Chart
Syncona News
IN BRIEF: Syncona's investee Autolus widens quarterly loss as costs up
Syncona Ltd - London-based healthcare & investment company - Reports quarterly loss for its portfolio company Autolus Therapeutics PLC as research cos...
IN BRIEF: Syncona invests GBP15 million more in OMass Therapeutics
Syncona Ltd - London-based investment company - Invests more into OMass Therapeutics, an Oxford University biotechnology spin-out. After the new GBP15...
Syncona takes part in oversubscribed funding round for OMass
(Sharecast News) - Syncona committed further funding for rare-disease specialist OMass Therapeutics alongside a syndicate of investors which included ...
Syncona's investee Anaveon receives good trial data
(Alliance News) - Syncona Ltd on Monday noted that its portfolio company Anaveon AG received "encouraging" first clinical data from its ongoing phase ...
Syncona's Anaveon to present first clinical data from ANV419 study
(Sharecast News) - Healthcare company Syncona said on Monday that its portfolio company, Anaveon AG, a clinical-stage immuno-oncology business, had an...
Syncona notes portfolio company Freeline annual loss widens in 2021
(Alliance News) - Syncona Ltd said on Friday that portfolio company Freeline Therapeutics Holdings PLC suffered a widened loss last year.
Syncona to invest further USD20 million in Freeline Therapeutics
(Alliance News) - Syncona Ltd said on Friday that it agreed to invest USD20.0 million in Freeline Therapeutics Holdings PLC, as part of the investee's...
Syncona completes USD1.5 billion sale of Gyroscope to Novartis
(Alliance News) - Syncona Ltd on Friday said it has completed the sale of Gyroscope Therapeutics Holding PLC to Novartis AG.
Follow the stocks
